Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
Nature Communications
Volume 7, Issue -, Pages 8994
Publisher
Springer Nature
Online
2016-02-03
DOI
10.1038/ncomms9994
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New paradigms for metabolic modeling of human cells
- (2015) Adil Mardinoglu et al. CURRENT OPINION IN BIOTECHNOLOGY
- Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism
- (2015) Francesco Gatto et al. Scientific Reports
- Quantitative profiling of bile acids in blood, adipose tissue, intestine, and gall bladder samples using ultra high performance liquid chromatography-tandem mass spectrometry
- (2014) Sirkku E. Jäntti et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease
- (2014) Adil Mardinoglu et al. Nature Communications
- Integration of clinical data with a genome-scale metabolic model of the human adipocyte
- (2013) A. Mardinoglu et al. Molecular Systems Biology
- Metabolic Associations of Reduced Proliferation and Oxidative Stress in Advanced Breast Cancer
- (2012) L. Jerby et al. CANCER RESEARCH
- Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT
- (2012) Rasmus Agren et al. PLoS Computational Biology
- LIBSVM
- (2012) Chih-Chung Chang et al. ACM Transactions on Intelligent Systems and Technology
- Data Analysis Tool for Comprehensive Two-Dimensional Gas Chromatography/Time-of-Flight Mass Spectrometry
- (2011) Sandra Castillo et al. ANALYTICAL CHEMISTRY
- Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease
- (2011) Nishanth E. Sunny et al. Cell Metabolism
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Comparison of Dorsocervical With Abdominal Subcutaneous Adipose Tissue in Patients With and Without Antiretroviral Therapy-Associated Lipodystrophy
- (2011) K. Sevastianova et al. DIABETES
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- iMAT: an integrative metabolic analysis tool
- (2010) Hadas Zur et al. BIOINFORMATICS
- Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects With Nonalcoholic Fatty Liver Disease
- (2010) Jukka Westerbacka et al. GASTROENTEROLOGY
- HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology
- (2010) Christoph Gille et al. Molecular Systems Biology
- α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
- (2010) Walter E. Gall et al. PLoS One
- Predicting metabolic biomarkers of human inborn errors of metabolism
- (2009) Tomer Shlomi et al. Molecular Systems Biology
- Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
- (2008) A. Kotronen et al. DIABETES
- Proteomic analysis of fructose-induced fatty liver in hamsters
- (2008) Lihe Zhang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Network-based prediction of human tissue-specific metabolism
- (2008) Tomer Shlomi et al. NATURE BIOTECHNOLOGY
- Fatty Liver
- (2007) Anna Kotronen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started